| Drug Name: | Mexiletine (31828-71-4) |
|---|---|
| PubChem ID: | 4178 |
| SMILES: | CC1=C(C(=CC=C1)C)OCC(C)N |
| InchiKey: | VLPIATFUUWWMKC-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Arrhythmia Agents, Cardiovascular Agents, Membrane Transport Modulators, Sodium Channel Blockers, Voltage-Gated Sodium Channel Blockers |
| Molecular Weight (dalton) | : | 179.263 |
| LogP | : | 2.02944 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 35.25 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Morphine (57-27-2) | Myocardial Infarction | Antagonistic | Uncertain | A trial of intravenous and oral mexiletine in acute myocardial infarction |
This panel provides drug-protein interaction and their ADRs along with references
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category